Temple University: Clinical Trials

23 trials sponsored by Temple University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 5 terminated, 3 unknown, 3 withdrawn. 23 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 423Completed 12, Terminated 5, Unknown 3, Withdrawn 3

Follow Temple University: new trials by email

Trials (filtered) newest first · largest first

All 23 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder
Dexmedetomidine, Lorazepam 2 MG/ML - Schizophrenia Agitation, Schizo Affective Disorder
Phase 4UnknownTemple University322023-07-012023-10-23
Comparison of Time to Extubation Using Sugammadex or Neostigmine
neostigmine/glycopyrrolate, sugammadex - Neuromuscular Blockade, Chronic Obstructive Pulmonary Disease
Phase 4CompletedTemple University582021-04-082024-03-13
Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients
Tacrolimus Extended Release Oral Tablet [Envarsus] 0.13mg/kg/day initiated within post-operative day 3 after kidney transplant - Kidney Transplant
Phase 4CompletedTemple University362018-11-122023-05-11
Investigation of Cannabinoid Receptor Agonist Dronabinol in Patients With Functional Chest Pain
Dronabinol, Placebo - Esophageal Diseases
Phase 4WithdrawnTemple University2017-06-212019-09-26
Liraglutide for HIV-associated Neurocognitive Disorder
Liraglutide - HIV Infection, Diabetes Mellitus Type 2
Phase 4TerminatedTemple University42016-09-012022-07-29
The Intra-arterial Vasospasm Trial
Nicardipine, Verapamil, Nicardipine + Verapamil + Nitroglycerin - Cerebral Vasospasm
Phase 4TerminatedPeng Roc Chen, MD922016-08-292025-05-11
Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain
Triamcinolone, Placebo, Lidocaine - Chronic Abdominal Wall Pain, Abdominal Cutaneous Nerve Entrapment Syndrome
Phase 4WithdrawnTemple University2016-05-012016-12-05
Comparison of Voice Therapy and Antireflex Therapy in LPR
Omeprazole, Lansoprazole, Esomeprazole, Rantidine, Voice therapy, Combination of anti-reflux medication and voice therapy - Laryngopharyngeal Reflux
Phase 4WithdrawnTemple University2016-05-012018-05-18
Chronic Hypertension and Pregnancy (CHAP) Project
Anti-hypertensive therapy, No anti-hypertensive therapy (unless BP is severe) - Hypertension
Phase 4CompletedUniversity of Alabama at Birmingham24082015-06-012023-05-17
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes
Liraglutide - Type 2 Diabetes
Phase 4UnknownTemple University122014-05-012022-07-29
Intervention to Promote Weight Loss in Latinas At-risk for Diabetes
Promotora-led Intervention, Metformin Therapy, Usual Care - Diabetes
Phase 4CompletedTemple University922013-09-012020-12-22
Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes
Sitagliptin, Basal Bolus, Metformin and Sitagliptin - Type 2 Diabetes
Phase 4CompletedEmory University2922013-08-012017-05-30
Telephone Based Management of Hyperlipidemia
Self Monitoring Lipid Analyzer - Hyperlipidemia
Phase 4CompletedTemple University702010-11-012026-04-07
Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)
lopinavir/ritonavir plus maraviroc - HIV Infections
Phase 4TerminatedTemple University12010-04-012020-11-02
Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy
PEG-3350 and Gatorade, Golytely 4 liters - Colon Cancer
Phase 4CompletedTemple University1362010-04-012017-09-13
Impact of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients
sirolimus - Glomerular Filtration Rate, Chronic Allograft Nephropathy
Phase 4UnknownTemple University502009-09-012009-10-21
Strict Glycemic Control by Insulin Infusion:Observations on Emergency Department Initiation
Insulin - Hyperglycemia
Phase 4CompletedTemple University272007-03-012017-03-16
Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients
Tegaserod - Chronic Constipation
Phase 4TerminatedNovartis602006-07-012016-03-04
Lansoprazole Preventing Gastroduodenal Stress Ulcerations
Lansoprazole - Patients Undergoing Elective Coronary Artery Bypass Graft
Phase 4TerminatedTemple University402005-09-012008-01-11
Rabeprazole Protection of Aspirin Induced Gastric Damage.
Rabeprazole - Normal Subjects
Phase 4CompletedTemple University302005-09-012008-01-11

Showing 20 of 23. Sign in to see all of them.

Conditions studied

Diabetes Mellitus (3)  ·  Diabetes Mellitus, Type 2 (3)  ·  Obesity (3)  ·  HIV Infections (2)  ·  Weight Loss (2)  ·  Anxiety Disorders (1)  ·  Bipolar Disorder (1)  ·  Colonic Neoplasms (1)  ·  Constipation (1)  ·  Esophageal Diseases (1)  ·  Hyperglycemia (1)  ·  Hyperlipidemias (1)  ·  Hypertension (1)  ·  Laryngopharyngeal Reflux (1)  ·  Lung Diseases (1)

Interventions

Caloric Restriction (2)  ·  Lansoprazole (2)  ·  Liraglutide (2)  ·  Cognitive Behavioral Therapy (1)  ·  Dexmedetomidine (1)  ·  Diet, Carbohydrate-Restricted (1)  ·  Dronabinol (1)  ·  Electrolytes (1)  ·  Esomeprazole (1)  ·  Glycopyrrolate (1)  ·  Insulin (1)  ·  Insulin Aspart (1)  ·  Insulin Glargine (1)  ·  Insulin Lispro (1)  ·  Labetalol (1)

Countries

United States (22)  ·  Australia (1)

Top investigators

Holly Wyatt, MD (2)  ·  James Hill, PhD (2)  ·  Robert S Fisher, MD (2)  ·  Samuel Klein, MD (2)  ·  Adam Diamond, PharmD (1)  ·  Ajaykumar D Rao, MD (1)  ·  Alan Tita, MD, PhD (1)  ·  Cherie Vaz, MD Dipl ABOM (1)  ·  Ellen Hauck, DO PhD (1)  ·  Frank Friedenberg, MD (1)  ·  Gary Cutter, PhD (1)  ·  Gary D Foster, PhD (1)  ·  Gary Foster, PhD (1)  ·  Guillermo Umpierrez, MD (1)  ·  Henry Parkman, M.D. (1)

Results publications

PMID 12161727, PMID 16481828, PMID 20082927, PMID 20679559, PMID 21760633, PMID 21908799, PMID 22653255, PMID 22711499, PMID 27964837, PMID 35363951, PMID 37437694, PMID 37769314, PMID 38781591, PMID 38949541

NIH funding

R01AT001103 (2), R01MH064484 (1), U01HL119242 (1)